Milestone Scientific (MLSS) Cash from Financing Activities (2011 - 2026)

Milestone Scientific has disclosed Cash from Financing Activities across 15 years of filings, most recently posting -$3428.0 for Q1 2026.

• Cash from Financing Activities for Q1 2026 came in at -$3428.0, down 50.48% year-over-year; the trailing twelve-month figure through Mar 2026 was $785185.0 (up 8002.43% YoY), and the FY2025 annual result was $786335.0, up 236.37% from the prior year.
• Cash from Financing Activities came in at -$3428.0 for Q1 2026 at Milestone Scientific, roughly flat from -$3414.0 in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $2.6 million in Q4 2023 to a low of -$4556.0 in Q3 2025.
• The 5-year median for Cash from Financing Activities is -$2171.0 (2022), against an average of $209933.5.
• Across the five-year window, Cash from Financing Activities plunged 102.87% in 2022 and soared 124843.49% in 2023, its largest moves.
• Milestone Scientific's Cash from Financing Activities stood at -$2058.0 in 2022, then jumped by 124843.49% to $2.6 million in 2023, then plunged by 100.1% to -$2523.0 in 2024, then tumbled by 35.32% to -$3414.0 in 2025, then dropped by 0.41% to -$3428.0 in 2026.
• The last three Cash from Financing Activities figures came in at -$3428.0 (Q1 2026), -$3414.0 (Q4 2025), and -$4556.0 (Q3 2025), per Business Quant data.